Desloratadine Glenmark 5 mg Tablets are indicated in adults and adolescents aged 12 years and older for the relief of symptoms associated with: - allergic rhinitis (See section 5.1) - urticaria (see section 5.1)
Multicenter, randomized, parallel-group, double-blind, comparative clinical trial of the superiority of the fixed-dose combination of desloratadine 0.5 mg/mL and prednisolone 4 mg/mL from Eurofarma Laboratórios SA versus desloratadine 0.5 mg/mL (Leg®) in the treatment of moderate to severe persistent allergic rhinitis in children aged 6 to 12 years.
Desloratadine is indicated in adults and adolescents aged 12 years or older for the relief of symptoms associated with: - allergic rhinitis (see section 5.1), - urticaria (see section 5.1).
Desloratadine Mylan is indicated in adults and adolescents aged 12 years and older for the relief of symptoms associated with: - allergic rhinitis (see section 5.1). - urticaria (see section 5.1).